{"id":"NCT01075282","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)","officialTitle":"A Randomized, Open-Label, Parallel-Arm, Noninferiority Comparison of the Effects of Two Doses of LY2189265 and Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Glimepiride","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2012-05","completion":"2012-11","firstPosted":"2010-02-25","resultsPosted":"2015-01-16","lastUpdate":"2015-01-16"},"enrollment":810,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"LY2189265","otherNames":["Dulaglutide"]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Glimepiride","otherNames":[]}],"arms":[{"label":"LY2189265 1.5 mg","type":"EXPERIMENTAL"},{"label":"LY2189265 0.75 mg","type":"EXPERIMENTAL"},{"label":"Insulin Glargine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if LY2189265 is effective in reducing hemoglobin A1c (HbA1c) and safe, as compared to Insulin Glargine in participants with Type 2 Diabetes. Participants must also be taking metformin and glimepiride.","primaryOutcome":{"measure":"Change From Baseline to 52 Weeks Endpoint in Glycosylated Hemoglobin (HbA1c)","timeFrame":"Baseline, 52 weeks","effectByArm":[{"arm":"LY2189265 1.5 mg","deltaMin":-1.08,"sd":0.06},{"arm":"LY2189265 0.75 mg","deltaMin":-0.76,"sd":0.06},{"arm":"Insulin Glargine","deltaMin":-0.63,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":78,"countries":["Argentina","Australia","Belgium","Brazil","Canada","Croatia","Czechia","France","Greece","Hungary","India","Italy","Mexico","Poland","Romania","Slovakia","South Korea","Spain","Sweden","Taiwan"]},"refs":{"pmids":["27161178","26691396","26089386"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":273},"commonTop":["Diarrhoea","Nausea","Nasopharyngitis","Urinary tract infection","Headache"]}}